Baker Bros. Advisors LP

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 89
Total Value: 9036702464
Accession Number: 0001104659-25-049518
Form Type: 13F-HR
CIK: 0001263508
Manager Name: Baker Bros. Advisors LP

Data Enrichment

94% identified

84 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

89 positions • $9,036,702.464K total value

89 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 2 of 5

Sort by:

Kodiak Sciences Inc.

KOD|50015M109

17310490(+0.0%)

Value:

$48.6B(-71.8%)

Nurix Therapeutics, Inc.

NRIX|67080M103

3882125(+0.0%)

Value:

$46.1B(-36.9%)

ARGENX SE

ARGX|04016X101

77760(-30.5%)

Value:

$46.0B(-33.1%)

Entrada Therapeutics, Inc.

TRDA|29384C108

4865819(+0.0%)

Value:

$44.0B(-47.7%)

Celcuity Inc.

CELC|15102K100

4257735(+59.0%)

Value:

$43.0B(+22.8%)

GRAIL, Inc.

GRAL|384747101

1630125(+0.0%)

Value:

$41.6B(+43.1%)

Roivant Sciences Ltd.

ROIV|G76279101

3767773(+0.0%)

Value:

$38.0B(-14.7%)

Immatics N.V.

IMTX|N44445109

7275830(+0.0%)

Value:

$32.8B(-36.6%)

Stoke Therapeutics, Inc.

STOK|86150R107

4633838(+0.0%)

Value:

$30.8B(-39.7%)

CERUS CORP

CERS|157085101

19351087(-0.6%)

Value:

$26.9B(-10.3%)

Vaxcyte, Inc.

PCVX|92243G108

640885(+1211.0%)

Value:

$24.2B(+504.7%)

Monte Rosa Therapeutics, Inc.

GLUE|61225M102

4916095(+0.0%)

Value:

$22.8B(-33.1%)

CRISPR Therapeutics AG

CRSP|H17182108

654099(-50.0%)

Value:

$22.3B(-56.8%)

Akero Therapeutics, Inc.

AKRO|00973Y108

548713(-50.0%)

Value:

$22.2B(-27.2%)

SERA PROGNOSTICS, INC.

SERA|81749D107

5498170(+1.2%)

Value:

$20.2B(-54.3%)

Centessa Pharmaceuticals plc

CNTA|152309100

1227178(+0.0%)

Value:

$17.6B(-14.1%)

Neurogene Inc.

NGNE|64135M105

1486200(+120.3%)

Value:

$17.4B(+12.9%)

IDEAYA Biosciences, Inc.

IDYA|45166A102

1062123(+0.0%)

Value:

$17.4B(-36.3%)

Verona Pharma plc

VRNA|925050106

223843

Value:

$14.2B

Candel Therapeutics, Inc.

CADL|137404109

2437189(-18.3%)

Value:

$13.8B(-46.8%)

Instrument	Shares		Other Manager	Value
Kodiak Sciences Inc.(KODcusip50015M109)	17.3M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$48.6M	QoQ -71.80% (-$123.7M) YoY -46.67% (-$42.5M)
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	3.9M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$46.1M	QoQ -36.94% (-$27.0M) YoY -19.18% (-$10.9M)
Argenx Se(ARGXcusip04016X101)	77.8K	QoQ -30.51% (-34.1K) YoY -48.57% (-73.5K)	All Managers (Combined)	$46.0M	QoQ -33.12% (-$22.8M) YoY -22.69% (-$13.5M)
Entrada Therapeutics, Inc.(TRDAcusip29384C108)	4.9M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$44.0M	QoQ -47.71% (-$40.1M) YoY -36.20% (-$25.0M)
Celcuity Inc.(CELCcusip15102K100)	4.3M	QoQ +58.95% (+1.6M) YoY +174.25% (+2.7M)	All Managers (Combined)	$43.0M	QoQ +22.76% (+$8.0M) YoY +28.36% (+$9.5M)
Grail, Inc.(GRALcusip384747101)	1.6M	QoQ 0.00% (+0) YoY NEW(+1.6M)	All Managers (Combined)	$41.6M	QoQ +43.08% (+$12.5M) YoY NEW(+$41.6M)
Roivant Sciences Ltd.(ROIVcusipG76279101)	3.8M	QoQ 0.00% (-0) YoY -49.17% (-3.6M)	All Managers (Combined)	$38.0M	QoQ -14.70% (-$6.6M) YoY -51.34% (-$40.1M)
Immatics N.V.(IMTXcusipN44445109)	7.3M	QoQ 0.00% (-0) YoY +12.91% (-832.4K)	All Managers (Combined)	$32.8M	QoQ -36.56% (-$18.9M) YoY -51.54% (-$34.9M)
Stoke Therapeutics, Inc.(STOKcusip86150R107)	4.6M	QoQ 0.00% (-0) YoY +37.56% (-1.3M)	All Managers (Combined)	$30.8M	QoQ -39.70% (-$20.3M) YoY -32.23% (-$14.7M)
Cerus Corp(CERScusip157085101)	19.4M	QoQ -0.64% (-126.3K) YoY -0.64% (-126.3K)	All Managers (Combined)	$26.9M	QoQ -10.32% (-$3.1M) YoY -26.93% (-$9.9M)
Vaxcyte, Inc.(PCVXcusip92243G108)	640.9K	QoQ +1211.00% (+592.0K) YoY +1211.00% (+592.0K)	All Managers (Combined)	$24.2M	QoQ +504.73% (+$20.2M) YoY +624.68% (+$20.9M)
Monte Rosa Therapeutics, Inc.(GLUEcusip61225M102)	4.9M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$22.8M	QoQ -33.14% (-$11.3M) YoY -34.18% (-$11.8M)
Crispr Therapeutics Ag(CRSPcusipH17182108)	654.1K	QoQ -49.99% (-653.9K) YoY NEW(+654.1K)	All Managers (Combined)	$22.3M	QoQ -56.76% (-$29.2M) YoY NEW(+$22.3M)
Akero Therapeutics, Inc.(AKROcusip00973Y108)	548.7K	QoQ -49.98% (-548.4K) YoY -79.77% (-2.2M)	All Managers (Combined)	$22.2M	QoQ -27.22% (-$8.3M) YoY -67.59% (-$46.3M)
Sera Prognostics, Inc.(SERAcusip81749D107)	5.5M	QoQ +1.17% (-63.8K) YoY +1.17% (-63.8K)	All Managers (Combined)	$20.2M	QoQ -54.26% (-$24.0M) YoY -59.08% (-$29.2M)
Centessa Pharmaceuticals Plc(CNTAcusip152309100)	1.2M	QoQ 0.00% (-0) YoY NEW(+1.2M)	All Managers (Combined)	$17.6M	QoQ -14.14% (-$2.9M) YoY NEW(+$17.6M)
Neurogene Inc.(NGNEcusip64135M105)	1.5M	QoQ +120.35% (+811.8K) YoY +225.91% (-1.0M)	All Managers (Combined)	$17.4M	QoQ +12.87% (+$2.0M) YoY -25.02% (-$5.8M)
Ideaya Biosciences, Inc.(IDYAcusip45166A102)	1.1M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$17.4M	QoQ -36.26% (-$9.9M) YoY -62.67% (-$29.2M)
Verona Pharma Plc(VRNAcusip925050106)	223.8K	QoQ NEW(+223.8K) YoY NEW(+223.8K)	All Managers (Combined)	$14.2M	QoQ NEW(+$14.2M) YoY NEW(+$14.2M)
Candel Therapeutics, Inc.(CADLcusip137404109)	2.4M	QoQ -18.26% (-544.8K) YoY NEW(+2.4M)	All Managers (Combined)	$13.8M	QoQ -46.79% (-$12.1M) YoY NEW(+$13.8M)